10 Jan 2023 ExeVir Bio secures EUR 25 million venture debt financing from the European Investment Bank Member news
09 Jan 2023 Foundational RNA and cLNP expert Antonin (Tony) de Fougerolles joins eTheRNA as independent board member Member news
06 Jan 2023 UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis filed with U.S. FDA and designated for Priority Review Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us